ANTX as of Nov 2 · 04:05 ET
ANTXNasdaqPharmaceutical Preparations
AN2 Therapeutics, Inc. · Brief
Next report
9 days
Nov 11 · after closeest.Q3 FY26
Expected move
No implied move.
—≥ implied
Q2 FY26±60.5%▲+6.98%×0.12
quarterimplied−65%0+65%realized×
Q2 FY26±60.5%▲+6.98%×0.12
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 11 report · est.Bull2
66managers reporting a position in the latest quarterly filings remain widely represented13F · Jun 30 '26
+21.71%shares held by the ten largest reporting managers rose over the latest quarter13F · Jun 30 '26
Bear2
15managers whose positions together make up four fifths of the reported value are concentrated13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
ANTX report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.